Clinical trial
Effect of Melatonin and Metformin Combination Therapy on Clinical and Biochemical Parameters inInsulin Resistant Polycystic Ovary Syndrome Compared to Metformin Alone
NCT07307677 is registered in ClinicalTrials.gov with Mst.Sumyara Khatun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Melatonin and Metformin Combination Therapy on Clinical and Biochemical Parameters inInsulin Resistant Polycystic Ovary Syndrome Compared to Metformin Alone
- Lead sponsor
- Mst.Sumyara Khatun
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 11, 2025
- Completion date
- August 10, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pcos(insulin resistant)